Vitura Health Ltd - Asset Resilience Ratio

Latest as of June 2024: 16.76%

Vitura Health Ltd (VIT) has an Asset Resilience Ratio of 16.76% as of June 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Vitura Health Ltd (VIT) total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

AU$11.94 Million

≈ $8.45 Million USD Cash + Short-term Investments

Total Assets

AU$71.28 Million

≈ $50.44 Million USD All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio Trend (2024–2024)

This chart shows how Vitura Health Ltd's Asset Resilience Ratio has changed over time. See Vitura Health Ltd (VIT) net assets for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Vitura Health Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see VIT market cap overview.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	AU$0.00	0%
Short-term Investments	AU$11.94 Million	16.76%
Total Liquid Assets	AU$11.94 Million	16.76%

Asset Resilience Insights

Good Liquidity Position: Vitura Health Ltd maintains a healthy 16.76% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company has significant short-term investments, indicating active treasury management.

Vitura Health Ltd Industry Peers by Asset Resilience Ratio

Compare Vitura Health Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Jiangsu Hengrui Medicine Co Ltd SHG:600276	Drug Manufacturers - Specialty & Generic	0.16%
Swedish Orphan Biovitrum AB (publ) ST:SOBI	Drug Manufacturers - Specialty & Generic	1.54%
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt F:RIG2	Drug Manufacturers - Specialty & Generic	0.20%
Regencell Bioscience Holdings Ltd NASDAQ:RGC	Drug Manufacturers - Specialty & Generic	43.05%
Shan Dong Dong-E E-Jiao Co Ltd SHE:000423	Drug Manufacturers - Specialty & Generic	20.44%
Beijing New Oriental Star Petrochemical Engineering Co Ltd SHE:002755	Drug Manufacturers - Specialty & Generic	24.59%
Henan Newland Pharmaceutical Co. Ltd. A SHE:301277	Drug Manufacturers - Specialty & Generic	31.63%
Hainan Shuangcheng Pharmaceut SHE:002693	Drug Manufacturers - Specialty & Generic	3.29%

Annual Asset Resilience Ratio for Vitura Health Ltd (2024–2024)

The table below shows the annual Asset Resilience Ratio data for Vitura Health Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-06-30	16.76%	AU$11.94 Million ≈ $8.45 Million	AU$71.28 Million ≈ $50.44 Million	--

pp = percentage points

About Vitura Health Ltd

AU:VIT Australia Drug Manufacturers - Specialty & Generic

Market Cap

$18.29 Million

AU$25.85 Million AUD

Market Cap Rank

#25292 Global

#1126 in Australia

Share Price

AU$0.04

Change (1 day)

+2.63%

52-Week Range

AU$0.04 - AU$0.07

All Time High

AU$0.96